Literatura científica selecionada sobre o tema "Maladie thrombo-Embolique"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Maladie thrombo-Embolique".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Artigos de revistas sobre o assunto "Maladie thrombo-Embolique"
Wagner, T. "Maladie thrombo-embolique veineuse". Revue des Maladies Respiratoires 25, n.º 2 (fevereiro de 2008): 27. http://dx.doi.org/10.1016/s0761-8425(08)74821-6.
Texto completo da fonteTromeur, C. "Maladie veineuse thrombo-embolique". Revue des Maladies Respiratoires Actualités 4, n.º 7 (dezembro de 2012): 725–32. http://dx.doi.org/10.1016/s1877-1203(12)70341-5.
Texto completo da fonteLorut, C., G. Meyer, C. Leroyer e F. Parent. "La maladie thrombo-embolique veineuse". Revue des Maladies Respiratoires 22, n.º 1 (fevereiro de 2005): 169–73. http://dx.doi.org/10.1016/s0761-8425(05)85452-x.
Texto completo da fonteDanchin, N. "La maladie veineuse thrombo-embolique". Annales de Cardiologie et d'Angéiologie 51, n.º 3 (2002): 123. http://dx.doi.org/10.1016/s0003-3928(02)00082-3.
Texto completo da fonteÉmile, Carole. "Grossesse et maladie thrombo-embolique veineuse". Option/Bio 32, n.º 629-630 (março de 2021): 26–28. http://dx.doi.org/10.1016/s0992-5945(21)00051-9.
Texto completo da fonteJahnaoui, N., S. Hammi, I. Id Ahmed, K. Marc, M. Soualhi, R. Zahraoui, J. Benamor, J. E. Bourkadi e G. Iraqi. "Tuberculose pulmonaire et maladie thrombo-embolique". Revue des Maladies Respiratoires 29 (janeiro de 2012): A112. http://dx.doi.org/10.1016/j.rmr.2011.10.370.
Texto completo da fonteMeyer, G. "Maladie veineuse thrombo-embolique et cancer". Journal des Maladies Vasculaires 36 (dezembro de 2011): S42—S47. http://dx.doi.org/10.1016/s0398-0499(11)70008-7.
Texto completo da fonteHorellou, M. H., G. Plu-Bureau e J. Lepercq. "Maladie thrombo-embolique veineuse et grossesse". La Revue de Médecine Interne 36, n.º 3 (março de 2015): 219–24. http://dx.doi.org/10.1016/j.revmed.2014.10.356.
Texto completo da fonteSgard, B. "Maladie veineuse thrombo-embolique – Session 2". Médecine Nucléaire 41, n.º 5 (setembro de 2017): 349–52. http://dx.doi.org/10.1016/j.mednuc.2017.07.004.
Texto completo da fonteCombe, S., e H. R. Büller. "Nouveaux traitements de la maladie thrombo-embolique veineuse". Journal des Maladies Vasculaires 36 (dezembro de 2011): S16—S19. http://dx.doi.org/10.1016/s0398-0499(11)70003-8.
Texto completo da fonteTeses / dissertações sobre o assunto "Maladie thrombo-Embolique"
Couturaud, Francis. "Risque de maladie thrombo-embolique veineuse chez les membres de familles au premier degré de patients ayant une maladie thrombo-embolique veineuse idiopathique". Lyon 1, 2006. http://www.theses.fr/2006LYO10184.
Texto completo da fonteRational : In patients with idiopathic venous thromboembolism (VTE), the risk of recurrent VTE is high and a large proportion of these patients carry inherited thrombophilia. Our hypothesis is that patients with idiopathic VTE without detectable inherited thrombophilia have a genetic prothrombotic state not yet discovered. Objective : To evaluate the risk of VTE in first degree relatives of patients with idiopathic VTE and with or without inherited thrombophilia. If our hypothesis is true, this risk should be similar, with or without thrombophilia. Methods : In this international multicentre study, 1778 first degree relatives of 348 propositus with objectively diagnosed idiopathic VTE were included. Relatives were classified as having “certain VTE”, “uncertain VTE” or “no VTE” according to a predefined and standardised questionnaire. All the propositus were tested for the Leiden mutation and the G20210A prothrombin gene mutation. Results : In multivariate analysis, when “uncertain VTE” were classified as “No VTE”, we observed a trend of an increased risk of VTE in first degree relatives of probants with an inherited thrombophilia (relative risk of 1,52 [0,98 – 2,37], p = 0,06); when “uncertain VTE” were classified as “certain VTE”, the relative risk of VTE was closed to 1. 0 (1,18 [0,87-1,60], p = 0,3). For each level of VTE diagnosis criteria precision, there was an increased risk of VTE in first degree relatives women and in relatives from younger probants. Conclusion : The presence of an inherited thrombophilia in patients with idiopathic VTE is weakly associated with an increased risk in their first degree relatives. This observation supports our scientific hypothesis. One the main implications of this study is that the prevention of VTE should not be proposed in only first degree relatives of patients with VTE and inherited thrombophilia
Yvorra, Serge. "La maladie veineuse thrombo-embolique ambulatoire : donnees epidemiologiques, etiologiques, et suivi". Aix-Marseille 2, 1992. http://www.theses.fr/1992AIX20856.
Texto completo da fontePérol, Maurice. "Maladie thrombo-embolique pulmonaire chronique, éléments du pronostic : à propos de 27 observations". Lyon 1, 1989. http://www.theses.fr/1989LYO1M360.
Texto completo da fonteRiemens, Paul. "La maladie thrombo-embolique et son coût : considérations générales et en long séjour". Bordeaux 2, 1990. http://www.theses.fr/1990BOR25281.
Texto completo da fonteChalayer, Emilie. "Myélome multiple et maladie thrombo-embolique veineuse : aspects épidémiologiques, économiques, physiopathologiques et pharmacologiques". Thesis, Saint-Etienne, 2015. http://www.theses.fr/2015STET007T/document.
Texto completo da fonteThe association between multiple myeloma and venous thromboembolic disease is well established. This incidence in myeloma is on average from 10 to 20%. It appears to be higher in newly diagnosed myeloma and immunomodulatory drugs such as thalidomide might significantly increase the risk. However, the risk of thrombosis due to these treatments is not yet well defined. First, we performed a review of these diseases in order to delimit the field of this study through a literature review. Then, we evaluated the incidence of venous thromboembolic disease in patients with myeloma and treated with immunomodulatory, identified the thrombotic risk factors and evaluated the thrombotic risk assessment based on the physicians choice, through an observational, multicenter, prospective French study. Moreover, we performed the medico-economic analysis of the only randomized trial conducted to date on the thrombophylaxis in patients with multiple myeloma treated with thalidomide in the first line of chemotherapy. This analysis showed a gain in quality of life associated with significant cost savings in the prevention of thrombosis by aspirin rather than heparin. Finally we performed two medical studies using thrombin generation test, a global assay that measures the overall tendency of a plasma sample to form thrombin. The first study was conducted to predict patients who will have thrombosis. The second is performed to know if a heparin resistance with the usual doses in this pathology, exists
Lanoy, Léonard Fisch Alain. "Maladie veineuse thrombo-embolique et voyage aérien de courte durée réalités et perspectives /". Créteil : Université de Paris-Val-de-Marne, 2009. http://doxa.scd.univ-paris12.fr:80/theses/th0512111.pdf.
Texto completo da fonteSCHAMBRI, YVES. "Maladie thrombo-embolique : quel bilan etiologique ? l'experience du chg de pamiers : 40 cas". Toulouse 3, 1989. http://www.theses.fr/1989TOU31107.
Texto completo da fonteBREHM, GAILHARD SYLVIE, e FRANCOIS GALLEGO. "Le risque thrombo-embolique chez le sujet age hospitalise : consequences sur l'utilisation des anticoagulants". Toulouse 3, 1988. http://www.theses.fr/1988TOU31194.
Texto completo da fonteDESCHLER, SERGE. "L'heparinotherapie dans la prevention de la maladie thrombo-embolique en traumatologie et en orthopedie". Strasbourg 1, 1987. http://www.theses.fr/1987STR10680.
Texto completo da fonteLAPEYRE, FRANCOIS. "Filtres caves percutanes et maladie thrombo-embolique : indications et resultats ; revue de 180 observations". Toulouse 3, 1989. http://www.theses.fr/1989TOU31096.
Texto completo da fonteCapítulos de livros sobre o assunto "Maladie thrombo-Embolique"
Vernhet Kovacsik, H. "Embolie pulmonaire et maladie thrombo-embolique". In Collection de la Société française d’imagerie cardiaque et vasculaire, 207–20. Paris: Springer Paris, 2009. http://dx.doi.org/10.1007/978-2-287-99166-0_17.
Texto completo da fontePlu-Bureau, G. "Contraception et maladie veineuse thrombo-embolique". In La Contraception en Pratique, 41–46. Elsevier, 2013. http://dx.doi.org/10.1016/b978-2-294-72785-6.00007-4.
Texto completo da fonteAya, G., D. Benhamou, F. Bolandard, M. Bonnin, E. Boselli, F. Broisin, B. Bryssine et al. "Maladie thrombo-embolique veineuse en post-partum". In Protocoles en anesthésie et analgésie obstétricales, 121–25. Elsevier, 2010. http://dx.doi.org/10.1016/b978-2-294-71053-7.00045-7.
Texto completo da fonteAya, G., F. Bayoumeu, D. Benhamou, F. Bolandard, M. P. Bonnet, M. Bonnin, E. Boselli et al. "Maladie thrombo-embolique veineuse en post-partum". In Protocoles en Anesthésie et Analgésie Obstétricales, 175–79. Elsevier, 2018. http://dx.doi.org/10.1016/b978-2-294-76011-2.00056-7.
Texto completo da fonteCohen, Ariel, Emmanuelle Berthelot-Garcias e Fanny Douna. "Examens diagnostiques dans la maladie veineuse thrombo-embolique". In Urgences cardio-vasculaires et situations critiques en cardiologie, 61–65. Elsevier, 2010. http://dx.doi.org/10.1016/b978-2-294-71196-1.50017-0.
Texto completo da fonteCohen, Ariel, Emmanuelle Berthelot-Garcias e Fanny Douna. "Procédure interventionnelle dans la maladie veineuse thrombo-embolique". In Urgences cardio-vasculaires et situations critiques en cardiologie, 141. Elsevier, 2010. http://dx.doi.org/10.1016/b978-2-294-71196-1.50032-7.
Texto completo da fonte